Breaking News, Promotions & Moves

Sirnaomics Names Francois Lebel Chief Medical Officer

Lebel brings broad drug development experience including immuno-oncology and nucleic acid therapeutics.

Sirnaomics Ltd., a biopharmaceutical company, appointed Francois Lebel, chief medical officer. Lebel previously served as senior vice president for preclinical and clinical development since July 2023. Lebel, a 30-year industry veteran, will oversee the clinical development of Sirnaomics’ lead therapeutic candidate, STP705, for the treatment of squamous cell carcinoma in situ, which is  currently in a Phase II clinical trial. Lebel has broad drug development experience including immu...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters